==== Reference: Usmani SS, Bedi G, Samuel JS, Singh S, Kalra S, Kumar P, et al. (2017) THPdb: Database of FDA-approved peptide and protein therapeutics. PLoS ONE 12(7) e0181748.====

Browse result page of THPdb

The total number entries retrieved from this search are 7
IDThPPIDNamePeptide SequenceLengthFunctional ClassificationDiseaseBrandCompanyPhysical AppearanceRoute of AdministartionCategoryTarget
1260Th1037Botulinum Toxin Type BMPVTINNFNYNDPIDNNNII Full view255IcNeurological DisorderMyoblocSolstice NeurosciencesClear and colorless to light-yellow sterile injectable solutionInjectionAntidystonic Agents Vesicle-associated membrane protein 2,Vesicle-associated membrane protein 1,Synaptotagmin-2
1261Th1037Botulinum Toxin Type BMPVTINNFNYNDPIDNNNII Full view255IcNeurological DisorderNeuroblocSolstice NeurosciencesClear and colourless to light yellow solutionIntramuscular InjectionAntidystonic Agents Vesicle-associated membrane protein 2,Vesicle-associated membrane protein 1,Synaptotagmin-2
1419Th1070Botulinum Toxin Type AMPFVNKQFNYKDPVNGVDIA Full view1296IcNeurological DisorderBOTOX AllerganSterile, vacuum-dried purified botulinum toxin type A, produced from fermentation of Hall strainClostridium botulinum type AIntramuscular, intradetrusor and intradermal useNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents Growth hormone receptor
1420Th1070Botulinum Toxin Type AMPFVNKQFNYKDPVNGVDIA Full view1296IcNeurological DisorderDysportIpsen PharmaceuticalsSterile vial for reconstitutionIntramuscular InjectionNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents Growth hormone receptor
1421Th1070Botulinum Toxin Type AMPFVNKQFNYKDPVNGVDIA Full view1296IcNeurological DisorderXeominMERZ AESTHETICSSterile white to off-white lyophilized powder after reconstitution with preservative-free 0.9% Saline for Injection.Intramuscular InjectionNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents Growth hormone receptor
1534Th1113Glatiramer AcetateEAYKAAEKAYAAKEAAKEAA Full view52IIaNeurological DisorderCopaxoneTeva Pharmaceutical IndustriesClear, colorless to slightly yellow, sterile, nonpyrogenic solutionSubcutaneous injectionN.A. N.A.
1812Th1203Peginterferon beta-1aNA Full view0IaNeurological DisorderPlegridyBiogen Canada IncSterile SolutionSubcutaneousNA